Document Detail


Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet.
MedLine Citation:
PMID:  20725138     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endothelin (ET) receptor antagonists are antihypertensive and renoprotective in angiotensin II (AngII)-induced hypertension if administered when AngII infusion commences, but their effects on established hypertension are poorly understood. We therefore tested the effects of intervening with an ETA (ABT-627) or ETB (A-192621) receptor antagonist after establishing hypertension with AngII (65 ng/min s.c.) plus 8% NaCl diet (AngII-HS) in rats. Prior to administration of ABT-627, AngII-HS and AngII-HS plus ABT-627 groups displayed robust hypertension (mean arterial pressure (MAP), 170 +/- 5 and 165 +/- 5 mm Hg versus 110 +/- 3 mm Hg in normal salt control rats at day 7, P < 0.05). Administering ABT-627 from day 8 of AngII-HS treatment prevented further rises in MAP (168 +/- 5 and 191 +/- 3 mm Hg at day 13 in AngII-HS plus ABT-627 and AngII-HS, P < 0.001), without blunting the significant increases in urinary protein (19-fold), albumin (25-fold), or MCP-1 excretion (6- to 8-fold) or the reduction in creatinine clearance. Administering A-192621 from day 8 mildly exacerbated AngII-HS induced hypertension (P < 0.05 for AngII-HS versus AngII-HS plus A-192621 on days 11 and 12 only) and reduced plasma nitrite/nitrate concentration (P < 0.05), without affecting proteinuria, albuminuria, or creatinine clearance. These results confirm the importance of ETA receptor signaling in maintaining AngII-HS hypertension and suggest that including ETB receptor blockade in therapeutic approaches to treating hypertension would be ineffective or even counterproductive.
Authors:
Erika I Boesen; Jennifer S Pollock; David M Pollock
Related Documents :
20019328 - Angiotensin ii induces a region-specific hyperplasia of the ascending aorta through reg...
20836698 - Lentiviral-human heme oxygenase targeting endothelium improved vascular function in ang...
17086018 - Angiotensin receptor blockade improves vascular compliance in healthy normotensive elde...
22326878 - Dp/dt(max) - a measure of 'baroinometry'
7366248 - Relationship between the measured and calculated colloid osmotic pressure of plasma and...
10423638 - The effects of delapril in combination with indapamide on glomerular filtration rate in...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Canadian journal of physiology and pharmacology     Volume:  88     ISSN:  1205-7541     ISO Abbreviation:  Can. J. Physiol. Pharmacol.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-20     Completed Date:  2011-01-13     Revised Date:  2011-07-26    
Medline Journal Info:
Nlm Unique ID:  0372712     Medline TA:  Can J Physiol Pharmacol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  802-7     Citation Subset:  IM    
Affiliation:
Vascular Biology Center, Medical College of Georgia, 1459 Laney Walker Boulevard, Augusta, GA 30912, USA. eboesen@mcg.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Kidney Injury / etiology,  physiopathology,  urine
Angiotensin II / pharmacology*
Animals
Antihypertensive Agents / pharmacology,  therapeutic use
Blood Pressure / drug effects,  physiology
Hypertension / chemically induced*,  complications,  drug therapy*,  physiopathology
Male
Nitrates / blood,  urine
Nitrites / blood,  urine
Pyrrolidines / pharmacology,  therapeutic use
Rats
Rats, Sprague-Dawley
Receptor, Endothelin A / antagonists & inhibitors*
Receptor, Endothelin B / antagonists & inhibitors*
Sodium Chloride, Dietary / pharmacology*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
HL64776/HL/NHLBI NIH HHS; HL74167/HL/NHLBI NIH HHS; P01 HL069999-09/HL/NHLBI NIH HHS; P01 HL095499-01A1/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/A 127722; 0/A 192621; 0/Antihypertensive Agents; 0/Nitrates; 0/Nitrites; 0/Pyrrolidines; 0/Receptor, Endothelin A; 0/Receptor, Endothelin B; 0/Sodium Chloride, Dietary; 11128-99-7/Angiotensin II
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Next Document:  Endothelin signaling via guanine exchange factor C3G in renal glomerular mesangial cells.